Skip to site menu Skip to page content

Connected Metered Dose Inhalers

By H&T Presspart
In this article, H&T Presspart's programme manager Benjamin Jung and US sales and business development director Dana Shears describe the role of connected devices in the treatment of asthma and COPD. They discuss the requirements for mass adoption and introduce their inhaler, the eDMI, which has connectivity fully enabled. Non-adherence to medication is a critical problem in healthcare, especially in the area of chronic disease. The resulting economic burden across all diseases is estimated to be between $100bn and $300bn in the US and €125bn (£108bn) in Europe. To find out more, download this free white paper.  
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content